Candida Vitale and the other fellows at MD Anderson's leukemia treatment center had known each other for only a few months, but they already were very tight. The nine of them shared a small office and were always hanging out on weekends. Dr. Tina Cascone demonstrates the Oncology Expert Advisor System powered by IBM Watson at the Thoracic Center at MD Anderson Hospital in Houston. She says the system provides physicians with accurate information to provide personalized cancer treatment. Rumor had it that he had finished med school in two years and had a photographic memory of thousands of journal articles and relevant clinical trials.

Four people stand, eyes squinting, on the verdant, freshly mowed field of Boston's Fenway Park. The smiles on their faces are broad, if a bit shy. They are among the lucky ones--the tiny share of people who fought and survived pancreatic cancer. The scene is from a photograph pinned to a cubicle at Beth Israel Deaconess Medical Center in Boston. "What is it about these four people on the field?" asks A. James Moser, co-director of the Pancreas and Liver Institute and director of the Pancreatic Cancer Research Institute at Beth Israel Deaconess Medical Center.

A team of researchers at the Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS) in Boston have been working on developing artificial intelligence (AI) tools with potential to significantly change and improve accuracy in cancer and other disease diagnosis. Noting that pathology methods for diagnosing disease have stayed largely the same for the past 100 years with tissue samples manually reviewed under a microscope, the investigative work suggests diagnostic accuracy can be improved by using computers to interpret pathology images. "Our AI method is based on deep learning, a machine-learning algorithm used for a range of applications including speech recognition and image recognition," said Dr. Andrew Beck director of Bioinformatics at the Cancer Research Institute at Beth Israel Deaconess Medical Center (BIDMC) in press release. Beck, who is also an associate professor at Harvard Medical School said the approach teaches machines to interpret the complex patterns and structure observed in real-life data by building multi-layer artificial neural networks thought to be similar to how the learning occurs in the brain neocortex, where thinking occurs. The Beck lab's approach was recently tested in a competition at the annual meeting of the International Symposium of Biomedical Imaging (ISBI) held in Prague, Czech Republic, in April. The test task involved examining lymph node images to determine whether or not breast cancer was present.

Provided by Ludwig Cancer Research Entry requirements: A minimum of an upper second class undergraduate degree in a relevant subject. Applicants whose first language is not English will be required to provide evidence of proficiency as required by the University of Oxford. All applications will be made via the University of Oxford online admissions system. Computational pathology: challenges and promises for tissue analysis.

During the American Society of Clinical Oncology (ASCO) conference, an early trial data was presented showing a drug with promising effects in cancer treatments. The new cancer drug was developed through the use artificial intelligence. Following the earlier discussions on the role of precision medicine in cancer treatment, scientists have developed a potential cancer cure by incorporating the advancement of technology and the sophistication of artificial intelligence in the field of medicine. In fact, Berg, an American biotechnology firm, created a scientific and technological approach of measuring the cells' biochemistry and feed it into a supercomputer. Based on the recently presented data at the biggest cancer conference in the world held in Chicago over the weekend, scientists have a discovered a way to combine the advances in artificial intelligence with medicine, creating the drug named BPM31510.

By tradition, reporters work through those reports each quarter to extract financial data for business news articles. There are two fundamental limitations of this approach. First, there are currently more than 4,000 publicly traded companies in the U.S. and almost 40,000 around the world. With its existing resources, even an organization as big as the Associated Press (AP) could only produce about 300 such stories in a timely fashion per quarter – and that left thousands of potential company earnings stories unwritten. Second, even though these stories are relatively easy to write, they involve a lot of repetitive work copying and pasting numbers – something even trained reporters find difficult to do with perfect accuracy.

Database-as-a-service offers multiple potential benefits, including lower database licensing and infrastructure costs, faster time to application development, and reduced administration overheads. These benefits are most likely to be experienced by database administrators and architects, although senior decision-makers and business users also stand to gain from having on-demand access to database services, rather than waiting for databases to be configured and deployed on dedicated physical or virtual server infrastructure. While 451 Research anticipates growing adoption of database-as-a-service (DBaaS), adoption is currently nascent compared with other cloud services, as enterprises look to make the most of their investments in on-premises database deployments, and also to identify the most appropriate workloads for transition or migration to DBaaS. This webinar explores the factors shaping those adoption trends, including the potential benefits and challenges to DBaaS adoption, the economics of the cloud as they relate to database workloads, and adoption lifecycles.

The Facebook Messenger platform boasts thousands of bots. Remember when AI-driven chatbots promised to be THE NEXT BIG THING? Yes, that was last week. And, yes, the hype has already subsided into an impotent whimper. At least, that's what new developer data from VisionMobile reveals.

Key Responsibilities The role will be based around machine learning activities and beyond as Research and Development is fast changing and challenging environment. Additional Information Degree qualified in fields such as Computer Science, Mathematics, Statistics, Machine Learning or artificial intelligence..... click apply for full job details

SparkCognition, the world's first cognitive security analytics company, has been named a finalist for the AIconics Awards, in two categories. The AIconics are the world's only independently-judged awards celebrating the drive, innovation and hard work in the international Artificial Intelligence Community, with the winners announced exclusively at The AI Summit, September 28 in San Francisco. SparkCognition develops cutting-edge machine learning that models physical and virtual assets, continuously learns from data, and derives intelligent insights to secure and protect infrastructure round the clock. The company's technology is capable of harnessing real time sensor data and learning from it continuously, allowing for more accurate risk mitigation and prevention policies to intervene and avert disasters. At The AI Summit European flagship in London back in May, AI Business received a huge number of AIconics entries across the AI technology vendor spectrum active in the UK and Europe– from the freshest startups all the way through to longstanding innovators such as IAG, DRYiCE, BY HCL Technologies and Artificial Solutions.